Back to top

Pharming’s Joenja granted marketing authorization by European Commission

Pharming (PHAR) Group announced that the European Commission has granted marketing authorization for Joenja, an oral, selective phosphoinositide 3-...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Pharming Group N.V. Sponsored ADR (PHAR)

Koninklijke Philips N.V. (PHG)

Pharming Group NV (PHGUF)